Bluebird Bio | Lånekapital

Loan Capital Endring Dato
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 63.17B 4.13B 2023-12
Arrowhead Research USD 263.06M 263.06M 2023-06
Gilead Sciences USD 23.19B 1.98B 2023-09
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Moderna USD 575M 0 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Bluebird Bio Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.